{"id":"W3032274390","doi":"10.1200/jco.2020.38.15_suppl.e13079","title":"A phase Ib/II study of eribulin with cyclophosphamide (EC) in patients (pts) with advanced breast cancer (ABC).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Infectious Diseases Centre","funders":"","keywords":"Medicine; Eribulin; Cyclophosphamide; Internal medicine; Docetaxel; Breast cancer; Toxicity; Metastatic breast cancer; Cancer; Gastroenterology; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001978926,0.001679382,0.002203992,0.0005980933,0.0004643343,0.001048499,0.000972891,0.00149023,0.003915521],"category_scores_gemma":[0.000935172,0.0007758238,0.001020927,0.0007539339,0.001133322,0.0009437609,0.0004939719,0.003313476,0.001147041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001058542,"about_ca_system_score_gemma":0.001945298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009700661,"about_ca_topic_score_gemma":0.002220185,"domain_scores_codex":[0.9993913,0.0003227462,0.00002892892,0.00008869817,0.00004769145,0.0001206693],"domain_scores_gemma":[0.99921,0.0001113093,0.0001114801,0.00006181945,0.00005178605,0.0004534838],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6332655,0.2063894,0.008787258,0.001085247,0.001238881,0.0005744264,0.0004700196,0.00349693,0.04724915,0.0004190342,0.003782416,0.09324189],"study_design_scores_gemma":[0.457944,0.5272341,0.007098445,0.00003636883,0.0003554158,0.0002917983,0.00006421674,0.0007860141,0.002784178,0.0001600648,0.003225597,0.00001973356],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9877663,0.00182063,0.0005737859,0.0004937022,0.0001162584,0.006158347,0.0006837466,0.0000772524,0.002309997],"genre_scores_gemma":[0.9828343,0.002130297,0.002671574,0.001375013,0.0002396036,0.00636045,0.001514524,0.00003130703,0.002842801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003915521,"threshold_uncertainty_score":0.01309872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1138903540859942,"score_gpt":0.517889981634441,"score_spread":0.4039996275484468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}